Muhammad Zaki Hidayatullah Fadlullah

10PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursHaematologyRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 23, 2026
Associations Between Two-Year Immune-Related Adverse Events and Psychological Distress and Subsequent Survival Outcomes Among ICI-Treated Survivors Diagnosed With Advanced Cancers in the US.

|Dec 21, 2025
Synovial sarcoma reprograms transcription by GBAF activation of polycomb targets and loss of CBAF enhancers.

Jinxiu Li, Li Li, Kyllie Smith-Fry

|Nov 11, 2025
Single-cell profiling reveals three endothelial-to-hematopoietic transitions with divergent isoform expression landscapes.

Wen Hao Neo, Muhammad Zaki Hidayatullah Fadlullah, Harshangda Bhatnagar

|May 12, 2025
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study.

Zoe Quandt, Anastasia Lucas, Samantha I Liang

|Mar 26, 2025
Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma.

Julie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski

|Mar 04, 2025
Multi-gene risk score for prediction of clinical outcomes in treatment-naïve metastatic castrate-resistant prostate cancer.

Muhammad Zaki Hidayatullah Fadlullah, David Nix, Cameron Herberts

Pageof 2

Frequent Collaborators

5 joint publications

Aik-Choon Tan

2 joint publications

Roshana Thambyrajah

2 joint publications

Georges Lacaud

2 joint publications

Arabella Young